Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Baptista

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 5, 2002
Antipsychotic drugs and obesity: is prolactin involved?T Baptista, A Lacruz, T Meza, et al.
British Journal of Pharmacology|July 12, 2011
The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphineDaniel T Baptista-Hon, Tarek Z Deeb, Nidaa A Othman, et al.
Advances in Physiology Education|September 2, 2021
Computer-based virtual laboratory simulations: LabHEART cardiac physiology practicalOlivia Monteiro, Anand Bhaskar, Anna K M Ng, et al.
The Journal of Biological Chemistry|June 7, 2013
The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portalsDaniel T Baptista-Hon, Tarek Z Deeb, Jeremy J Lambert, et al.
Anesthesiology|August 19, 2017
Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor StimulationFiona A Bull, Daniel T Baptista-Hon, Claire Sneddon, et al.
Pharmacopsychiatry|January 5, 2002
Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administrationT Baptista, A Lacruz, F Angeles, et al.
British Journal of Pharmacology|February 8, 2021
TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor numberSamuel Singleton, Daniel T Baptista-Hon, Emily Edelsten, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1989
Mechanism of the body weight increase induced by systemic sulpirideM A Parada, L Hernandez, X Paez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2008
Anorectal lymphogranuloma venereum: the first two confirmed cases in PortugalR Castro, T Baptista, A Vale, et al.
Pharmacopsychiatry|January 21, 2009
Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trialT Baptista, N Rangel, Y El Fakih, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 5, 2002
Antipsychotic drugs and obesity: is prolactin involved?T Baptista, A Lacruz, T Meza, et al.
British Journal of Pharmacology|July 12, 2011
The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphineDaniel T Baptista-Hon, Tarek Z Deeb, Nidaa A Othman, et al.
Advances in Physiology Education|September 2, 2021
Computer-based virtual laboratory simulations: LabHEART cardiac physiology practicalOlivia Monteiro, Anand Bhaskar, Anna K M Ng, et al.
The Journal of Biological Chemistry|June 7, 2013
The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portalsDaniel T Baptista-Hon, Tarek Z Deeb, Jeremy J Lambert, et al.
Anesthesiology|August 19, 2017
Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor StimulationFiona A Bull, Daniel T Baptista-Hon, Claire Sneddon, et al.
Pharmacopsychiatry|January 5, 2002
Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administrationT Baptista, A Lacruz, F Angeles, et al.
British Journal of Pharmacology|February 8, 2021
TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor numberSamuel Singleton, Daniel T Baptista-Hon, Emily Edelsten, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1989
Mechanism of the body weight increase induced by systemic sulpirideM A Parada, L Hernandez, X Paez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2008
Anorectal lymphogranuloma venereum: the first two confirmed cases in PortugalR Castro, T Baptista, A Vale, et al.
Pharmacopsychiatry|January 21, 2009
Rosiglitazone in the assistance of metabolic control during olanzapine administration in schizophrenia: a pilot double-blind, placebo-controlled, 12-week trialT Baptista, N Rangel, Y El Fakih, et al.
Pageof 11